A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST).Ping Chi, William D. Tap, Cristina R. Antonescu et al.|Journal of Clinical Oncology|2020Cited by 21
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, William D. Tap, Li‐Xuan Qin et al.|Clinical Cancer Research|2022Cited by 16
A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma.Evan Rosenbaum, Sandra P. D’Angelo, Sujana Movva et al.|Journal of Clinical Oncology|2021Cited by 12
Supplementary Figure from Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, William D. Tap, Li‐Xuan Qin et al.|Unknown|2023Cited by 0
Supplementary Figure from Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, William D. Tap, Li‐Xuan Qin et al.|Unknown|2023Cited by 0